Granite FO LLC’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2K Hold
14
– – ﹤0.01% 147
2026
Q2
$2.19K Hold
14
– – ﹤0.01% 139
2026
Q1
$2.14K Hold
14
– – ﹤0.01% 141
2025
Q4
$1.93K Hold
14
– – ﹤0.01% 154
2025
Q3
$1.8K Hold
14
– – ﹤0.01% 168
2025
Q2
$1.69K Hold
14
– – ﹤0.01% 169
2025
Q1
$1.56K Hold
14
– – ﹤0.01% 168
2024
Q4
$1.36K Hold
14
– – ﹤0.01% 174
2024
Q3
$1.61K Buy
+14
New +$1.59K ﹤0.01% 168
2024
Q2
– Sell
-14
Closed -$1.68K – 151
2024
Q1
$1.68K Buy
+14
New +$1.44K ﹤0.01% 181

Other funds holding NVS

Granite FO LLC's NVS Position: Q3 2026 in Review

Granite FO LLC held its Novartis (NVS) position steady in Q3 2026 at 14 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #147.

Granite FO LLC first reported a position in NVS in Q1 2024 and has held it in 10 quarters since. The position peaked at $2.19K in Q2 2026. 944 funds tracked by Wall St. Rank hold NVS as of Q3 2026.

  • Granite FO LLC held 14 shares of Novartis worth $2K as of Q3 2026.
  • Granite FO LLC left its Novartis share count unchanged in Q3 2026.
  • Novartis made up ﹤0.01% of Granite FO LLC's portfolio in Q3 2026, its #147 holding.
  • Granite FO LLC first reported a position in Novartis in Q1 2024 and has held it in 10 quarters since.
  • Granite FO LLC's Novartis position peaked at $2.19K in Q2 2026.
  • 944 funds tracked by Wall St. Rank held Novartis as of Q3 2026.

Based on Granite FO LLC's 13F filing for Q3 2026, filed 14 Oct 2026.